Nadarajah Sreeharan

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Urinary Incontinence

Coronavirus Disease

Top Venues

Pharmaceutical medicine

Asia-Pacific journal of public health

Tropical doctor

Drugs - real world outcomes

University of Jaffna

University of Leeds (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Jaffna Jan 01 2016

Sri Lanka

Visiting Professorof Medicine :: Medicine

Kings College London Jan 01 2012

United Kingdom

Visiting Professor :: Faculty of Medicine and Life Sciences

GlaxoSmithKline Research and Development Oct 01 1986 - Jun 30 2007

United Kingdom

Increasing roles to Senior Vice President & European Medical Director :: European Medical Department

Education History

University of Leeds Jan 01 1976 - Sep 01 1979

United Kingdom

PHD :: Cardiovascular Studies

Publications

Thiyahiny S Navaratinaraja, Thirunavukarasu Kumanan, Suthasini Siraj, Nadarajah Sreeharan
Potential Drug-Drug Interactions Among Hospitalised Elderly Patients in Northern Sri Lanka, A Lower Middle-Income Country: A Retrospective Analysis. Drugs - real world outcomes (2022)
Rajmeet Jandu, Carl Naraynassamy, Nadarajah Sreeharan
Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK. Pharmaceutical medicine 36 (5) (2022)
Thirunavukarasu Kumanan, Chrishanthi Rajasooriyar, Mahesan Guruparan, Nadarajah Sreeharan
The Impact of COVID-19 on the Delivery of Critical Health Care: Experience From a Non-High-Income Country. Asia-Pacific journal of public health 32 (8) (2020)
Nadarajah Sreeharan
Clinical null hypothesis: Fisher revisited. Tropical doctor 49 (3) (2019)